Use of complementary and alternative medicine among breast cancer survivors in Taiwan

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4789-4792

  Wang, Hsiu Ho ^a   Chung, Ue Lin ^b  

^a YUANPEI UNIVERSITY   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

Breast cancer survivors; CAM use; Taiwan

Indexed keywords

EID: 84874011983     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4789     Document Type: Article

References (21)

1. Correa-Velez I, Clavarino A, Eastwood H (2005). Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med, 8, 953-61.
2. Demark-Wahnefried W, Peterson B, McBride C, et al (2000). Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer, 88, 674-84.
3. Eide M, Pederson AM (2009). God, disease, and spiritual dilemmas: reading the lives of women with breast cancer. Zygon: J Religion Sci, 44, 85-96.
4. Gorsuch R (1983). Factor Analysis (2nd. Ed). Hillsdale, NJ: Erlbaum.
5. Hamilton AS, Miller MF, Arora NK, et al (2012). Predictors of use of complementary and alternative medicine by non-hodgkin lymphoma survivors and relationship to quality of life. Integr Cancer Ther, 12. doi: 10.1177/1534735412449733
6. Helyer LK, Chin S, Chui BK, et al (2006). The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study. BMC Cancer, 6, 39.
7. Henderson JW and Donatelle RJ (2004). Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med, 10, 52-7.
8. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA: A Cancer J Clin, 61, 69-90.
9. Lengacher CA, Bennett MP, Kip KE, et al (2002). Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum, 29, 1445-52.
10. Lynn M (1986). Determination and quantification of content validity. Nurs Res, 35, 382-5.
11. Magné N, Melis A, Chargari C, et al (2011). Recommendations for a lifestyle which could prevent breast cancer and its relapse: Physical activity and dietetic aspects. Critical Rev Oncol / Hemat, 80, 450-9.
12. Molassiotis A, Fernandez-Ortega P, Pud D, et al (2005). Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol, 16, 655-63.
13. Moran MS, Ma S, Jagsi R, et al (2012). A Prospective, Multicenter Study of Complementary/ Alternative Medicine (CAM) Utilization During Definitive Radiation for Breast Cancer. Int J Radiat Oncol Biol Phys, Jun 1. (Articles in print)
14. National Center for Complementary and Alternative Medicine (2011). Available on-line at: http://nccam.nih.gov/health/ whatiscam/ (2012, 08-04).
15. Nazik E, Nazik H, Api M, et al (2012). Complementary and alternative medicine use by gynecologic oncology patients in Turkey. Asian Pac J Cancer Prev, 13, 21-5.
16. Richardson MA, Ma○sse LC, Nanny K, et al (2004). Discrepant views of oncologists and cancer patients on complementary/ alternative medicine. Support Care Cancer, 12, 797-804.
17. Shaharudin SH, Sulaiman S, Emran NA, et al (2011). The use of complementary and alternative medicine among Malay breast cancer survivors. Altern Ther Health Med, 17, 50-6.
18. Thomas KJ, Nicholl JP, Coleman P (2001). Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med, 9, 2-11.
19. Wang HH, Chung UL (2012). Breast cancer survivors' efforts to renew and preserve their health in Taiwan. Asian Pac J Cancer Prev, 13, 3195-201.
20. Wanchai A, Armer JM, Stewart BR (2010). Complementary and alternative medicine use among women with breast cancer: a systematic review. Clin J Oncol Nurs, 14, 45-55.
21. Xue CCL, Zhang AL, Lin V, et al (2007). Complementary and alternative medicine use in Australia: a national populationbased survey. J Altern Complement Med, 13, 643-50.